InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Anderman Jonathan. Officer active across 1 company, notably Compass Therapeutics, Inc.. Cumulatively, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 7 April 2025. The latest transaction was filed on 7 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration